Moderna, Inc. (NASDAQ:MRNA) announced on Friday that it has submitted a marketing application to the U.S. Food and Drug Administration (FDA) for review of its updated COVID-19 vaccine. The revised ...

The Senate released a report revealing that Biden administration health officials were less than honest about the dangers associated with COVID-19 vaccines.

I'm a clinical academic, which is quite a rare breed of doctor, because what I'm doing, along with other clinical academics, ...

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.

Analysts believe each of the stocks below has the potential to at least double in price, although the three firms also carry varying levels of risk.

Moderna (MRNA), and Novavax (NVAX) agree as the FDA advisors recommend targeting JN.1 strain for updated COVID vaccines this ...